Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14576 - 14600 of 15480 in total
Experimental
Experimental
Experimental
VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA). It acts as a p38 MAP kinase inhibitor. In the future, VX-702 may be investigated for combination with methotrexate, a commonly used therapy for RA.
Investigational
AKI-001 is an aurora kinase inhibitor.
Experimental
Experimental
Experimental
Indalpine was one of the first selective serotonin reuptake inhibitors to reach the American market. It was initially marketed by Pharmuka. However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported hematological effects caused by Indalpine, it was abruptly withdrawn from the US market.
Investigational
Withdrawn
Matched Description: … However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported …
Piromelatine has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Displaying drugs 14576 - 14600 of 15480 in total